EDGEWISE THERAPEUTICS INC (EWTX)

US28036F1057 - Common Stock

31.98  +0.03 (+0.09%)

After market: 31.93 -0.05 (-0.16%)

Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to EWTX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 43.25. This target is 35.23% above the current price.
EWTX was analyzed by 12 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about EWTX.
In the previous month the buy percentage consensus was at a similar level.
EWTX was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 31.9833.3342.8443.2553.55 - 4.22% 33.96% 35.23% 67.45%
Up and Down Grades
Date Firm Action Rating
2024-11-08 Wedbush Maintains Outperform -> Outperform
2024-10-11 Piper Sandler Maintains Overweight -> Overweight
2024-09-20 RBC Capital Maintains Outperform -> Outperform
2024-09-19 Truist Securities Maintains Buy -> Buy
2024-09-17 RBC Capital Maintains Outperform -> Outperform
2024-08-16 Wedbush Reiterate Outperform -> Outperform
2024-08-12 JP Morgan Maintains Overweight -> Overweight
2024-07-25 RBC Capital Reiterate Outperform -> Outperform
2024-07-10 RBC Capital Reiterate Outperform -> Outperform
2024-07-09 JP Morgan Maintains Overweight -> Overweight
2024-07-01 Piper Sandler Maintains Overweight -> Overweight
2024-06-26 Wedbush Reiterate Outperform -> Outperform
2024-04-22 RBC Capital Maintains Outperform -> Outperform
2024-04-17 Truist Securities Maintains Buy -> Buy
2024-04-16 Wedbush Reiterate Outperform -> Outperform
2024-03-12 RBC Capital Reiterate Outperform -> Outperform
2024-03-07 Piper Sandler Initiate Overweight
2023-11-10 Wedbush Maintains Outperform -> Outperform
2023-08-16 Wedbush Reiterate Outperform -> Outperform
2023-08-11 Wedbush Reiterate Outperform -> Outperform
2023-06-30 JP Morgan Maintains Overweight -> Overweight
2023-06-28 RBC Capital Reiterate Outperform -> Outperform
2023-06-28 Truist Securities Reiterate Buy -> Buy
2023-06-27 Truist Securities Reiterate Buy -> Buy
2023-05-16 JP Morgan Maintains Overweight -> Overweight
2023-05-12 Wedbush Reiterate Outperform -> Outperform
2023-05-01 Truist Securities Initiate Buy
2022-11-04 RBC Capital Maintains Outperform
2022-08-25 Goldman Sachs Downgrade Neutral -> Sell
2022-05-24 Goldman Sachs Maintains Neutral